Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-dopa and Celecoxib for Acute to Chronic Back Pain Transition
NCT04082715Phase 2Withdrawn
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Oct 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of carbidopa + levodopa in back pain, sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Planned start Oct 2019; status: withdrawn.
02
Drugs
carbidopa + levodopa
03
Conditions
back pain
Beyond the preview
Go deeper on NCT04082715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04082715.